This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Probiotic strains of lactobacilli are increasingly being used in clinical practice because of their many health benefits. Infections associated with probiotic strains of lactobacilli are extremely rare. We describe 2 patients who received probiotic lactobacilli and subsequently developed bacteremia and sepsis attributable to Lactobacillus species. Molecular DNA fingerprinting analysis showed that the Lactobacillus strain isolated from blood samples was indistinguishable from the probiotic strain ingested by the patients. This report indicates, for the first time, that invasive disease can be associated with probiotic lactobacilli. This report should not discourage the appropriate use of Lactobacillus or other probiotic agents but should serve as a reminder that these agents can cause invasive disease in certain populations.
- Accepted September 30, 2004.
- Copyright © 2005 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- Lactobacillus: the not so friendly bacteria
- Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?
- Key Roles of Human Polymorphonuclear Cells and Ciprofloxacin in Lactobacillus Species Infection Control
- Mechanisms and therapeutic effectiveness of lactobacilli
- Probiotics for Preterm Infants: A Premature or Overdue Necrotizing Enterocolitis Prevention Strategy?
- Probiotic-Associated Aspiration Pneumonia Due to Lactobacillus rhamnosus
- A Lactobacillus rhamnosus GG-derived Soluble Protein, p40, Stimulates Ligand Release from Intestinal Epithelial Cells to Transactivate Epidermal Growth Factor Receptor
- The Incidence of Necrotizing Enterocolitis Is Increased Following Probiotic Administration to Preterm Pigs
- Probiotics and Prebiotics in Pediatrics
- Commensal Escherichia coli Reduces Epithelial Apoptosis through IFN-{alpha}A-Mediated Induction of Guanylate Binding Protein-1 in Human and Murine Models of Developing Intestine
- Decrease in Frequency of Liquid Stool in Enterally Fed Critically Ill Patients Given the Multispecies Probiotic VSL#3: A Pilot Trial
- Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials
- Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial
- Live and Ultraviolet-Inactivated Lactobacillus Rhamnosus GG Decrease Flagellin-Induced Interleukin-8 Production in Caco-2 Cells
- Consider microbial cause
- Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial
- Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity
- Safety of probiotics: comparison of two popular strains
- Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model
- Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials.
- Intraspecific Genotypic Characterization of Lactobacillus rhamnosus Strains Intended for Probiotic Use and Isolates of Human Origin
- Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
- Probiotic use in clinical practice: what are the risks?
- Necrotizing Enterocolitis: Relationship to Innate Immunity, Clinical Features, and Strategies for Prevention
- Lactobacillus Sepsis Associated With Probiotic Therapy: In Reply
- Lactobacillus Sepsis Associated With Probiotic Therapy